Trial · NCT06703177
Registered outcomes16
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
1 to 16 of 16
Download this page as JSON| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | RP2D (Phase 1) | Screening up to study completion, an average of 1 year. | |
| Primary | AE (Phase 1) | Screening up to study completion, an average of 1 year. | |
| Primary | Objective response rate (ORR) (Phase 2) | Screening up to study completion, an average of 1 year. | |
| Secondary | Objective response rate (ORR) (Phase 1) | Screening up to study completion, an average of 1 year. | |
| Secondary | Disease control rate (DCR) (Phase 1) | Screening up to study completion, an average of 1 year. | |
| Secondary | Duration of response (DoR) (Phase 1) | Screening up to study completion, an average of 1 year. | |
| Secondary | Progression-free survival (PFS) (Phase 1) | Screening up to study completion, an average of 1 year. | |
| Secondary | Overall survival (OS) (Phase 1) | Screening up to study completion, an average of 1 year. | |
| Secondary | Drug Resistant Antibody (ADA) (Phase 1) | Screening up to study completion, an average of 1 year. | |
| Secondary | Blood concentration of SHR-1826 (Phase 1) | Screening up to study completion, an average of 1 year. | |
| Secondary | Blood concentration of free toxin SHR169265 (Phase 1) | Screening up to study completion, an average of 1 year. | |
| Secondary | Disease control rate (DCR) (Phase 2) | Screening up to study completion, an average of 1 year. | |
| Secondary | Duration of response (DoR) (Phase 2) | Screening up to study completion, an average of 1 year. | |
| Secondary | Progression-free survival (PFS) (Phase 2) | Screening up to study completion, an average of 1 year. | |
| Secondary | Overall survival (OS) (Phase 2) | Screening up to study completion, an average of 1 year. | |
| Secondary | AE (Phase 2) | Screening up to study completion, an average of 1 year. |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT06703177/registered